کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3386962 | 1220683 | 2010 | 5 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Amélioration du processus décisionnel pour l'application du décret APSIÂ : l'expérience française
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
ایمونولوژی، آلرژی و روماتولوژی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
New requirements for the preparation and delivery of named patient products (NPPs) were introduced by the French authorities in February 2004. A working group composed of representatives of allergist and manufacturers, named “APSI”, was created. This group set up a decision-making process to establish a list of clinically relevant allergen extracts in line with these new requirements. This list was then submitted for validation to the French Drug Regulatory Agency (Agence française de sécurité sanitaire des produits de santé [Afssaps]). A list of 66Â mother preparations was published by Afssaps in December 2007. This procedure guaranteed French allergists that the available allergen extracts are clinically relevant and that their quality is consistent with international recommendations, which benefits patients, the medical community and manufacturers. It is the first time in Europe that NPPs have been registered by governmental authorities. This action needs to go on.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revue Française d'Allergologie - Volume 50, Issue 3, April 2010, Pages 141-145
Journal: Revue Française d'Allergologie - Volume 50, Issue 3, April 2010, Pages 141-145
نویسندگان
F. de Blay, V. Doyen, E. Bloch-Morot, D. Caillot, J. Gayraud, A. de Laval, A. Thillay, P. Vassal, the APSI Group the APSI Group,